Abstract
To be effective, a designed drug must discriminate successfully the macromolecular target from alternative structures present in the organism. The last few years have witnessed the emergence of different computational tools aimed to the understanding and modeling of this process at molecular level. Although still rudimentary, these methods are shaping a coherent approach to help in the design of molecules with high affinity and specificity, both in lead discovery and in lead optimization. It is the purpose of this review to illustrate the array of computational tools available to consider selectivity in the design process, to summarize the most relevant applications, and to sketch the challenges ahead.
Keywords: Bioinformatics, receptor-based drug design, docking, ligand selectivity
Current Topics in Medicinal Chemistry
Title: Computational Approaches to Model Ligand Selectivity in Drug Design
Volume: 6 Issue: 1
Author(s): Angel R. Ortiz, Paulino Gomez-Puertas, Alejandra Leo-Macias, Pedro Lopez-Romero, Eduardo Lopez-Vinas, Antonio Morreale, Marta Murcia and Kun Wang
Affiliation:
Keywords: Bioinformatics, receptor-based drug design, docking, ligand selectivity
Abstract: To be effective, a designed drug must discriminate successfully the macromolecular target from alternative structures present in the organism. The last few years have witnessed the emergence of different computational tools aimed to the understanding and modeling of this process at molecular level. Although still rudimentary, these methods are shaping a coherent approach to help in the design of molecules with high affinity and specificity, both in lead discovery and in lead optimization. It is the purpose of this review to illustrate the array of computational tools available to consider selectivity in the design process, to summarize the most relevant applications, and to sketch the challenges ahead.
Export Options
About this article
Cite this article as:
Ortiz R. Angel, Gomez-Puertas Paulino, Leo-Macias Alejandra, Lopez-Romero Pedro, Lopez-Vinas Eduardo, Morreale Antonio, Murcia Marta and Wang Kun, Computational Approaches to Model Ligand Selectivity in Drug Design, Current Topics in Medicinal Chemistry 2006; 6 (1) . https://dx.doi.org/10.2174/156802606775193338
DOI https://dx.doi.org/10.2174/156802606775193338 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors
Current Medicinal Chemistry Categorization & Recognition of Lung Tumor Using Machine Learning Representations
Current Medical Imaging Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets Cervical Cancer During Pregnancy – An Approach to Diagnosis and Management
Current Women`s Health Reviews Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
Current Medicinal Chemistry Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
Current Diabetes Reviews Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer
Current Pharmaceutical Design Glucocorticoid Receptor Antagonists
Current Topics in Medicinal Chemistry Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Dendritic Nanoparticles for Cutaneous Drug Delivery - Testing in Human Skin and Reconstructed Human Skin
Current Pharmaceutical Design Current Concepts on the Management of Chordoma
Current Drug Therapy Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches
CNS & Neurological Disorders - Drug Targets Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Metabolism Evolution Based on Network Degrees of Orthologous Enzymes
Current Topics in Medicinal Chemistry Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery
Current Pharmaceutical Design Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Current Drug Therapy Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors
Current Medicinal Chemistry An Update of Patents, Preclinical and Clinical Outcomes of Lipid Nanoparticulate Systems
Current Pharmaceutical Design Epigenetic Lesions in Malignant Melanoma
Current Pharmaceutical Biotechnology An Engrossing History of Azidothymidine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)